Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$27.39 +1.19 (+4.54%)
At close: Nov 10, 2026 · 4:00 PM EST

Arcutis Biotherapeutics (ARQT) Preferred Stock Liabilities (2019)

Updated

Arcutis Biotherapeutics (ARQT) recorded Preferred Stock Liabilities of $166.49 million in Q4 2019, up 130.4% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Preferred Stock Liabilities (2019) Analysis & Trends

Starting with Q1 2019, Arcutis Biotherapeutics' Preferred Stock Liabilities history includes 4 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $72.25 million in FY2018.
  • Per Business Quant, the preceding three quarters came in at $72.25 million (Q3 2019), $72.25 million (Q2 2019) and $72.25 million (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Arcutis Biotherapeutics 3.53 Bn 2.65 Bn 131.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 166.49 Mn
Sep 30, 2019 72.25 Mn
Jun 30, 2019 72.25 Mn
Mar 31, 2019 72.25 Mn
API Access

Arcutis Biotherapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ARQT&period=max&api_key=YOUR_API_KEY